- SenesTech, a rodent fertility control innovator, just announced that its ContraPest(R) line of products is now registered for sale and immediate use in Puerto Rico
- Entry into Puerto Rico allows the company to tap into this lucrative market while also offering a viable solution to a problem that has posed a considerable threat to the island
- Fertility control works by fixing the root cause of the problem- rats’ incredible rate of reproduction
- Discussions are underway a large agricultural firm in the region to be the lead customer, opening the company up to new opportunities in the region
SenesTech (NASDAQ: SNES), a rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats, just announced that its ContraPest(R) line of products are now registered for sale and immediate use in Puerto Rico. This adds to the company’s winning streak for the 2023 calendar year, having just recently launched its Evolve(TM) Soft Bait product at Ace Hardware franchise locations in California and closing a public offering that resulted in gross proceeds of $5 million (https://ibn.fm/GhUoI), quintupling its market cap.
Since its inception in 2004, SenesTech has been committed to its mission to improve the health of our world by humanely managing animal populations through fertility control. It has also been guided by the vision to lead responsible and innovative solutions for a better world, embodying five central…
NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com
InvestorWire is powered by IBN
